TRB Chemedica International

TRB Chemedica International Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TRB Chemedica International, Route des Jeunes 33bis, Eaux-Vives.

For over 40 years, TRB Chemedica International have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology. TRB Chemedica is a Swiss pharmaceutical company, focus on research & development in specific therapeutic areas, including rheumatology, ophthalmology and neurology.

07/11/2025

Join us on Monday, December 1, from 6:00 PM to 7:00 PM (CET) for an expert-led TRB Academy session with Prof. Alkis Kalliakmanis.
Register now: https://bit.ly/3XhPHuc

📌 Topic: Optimizing Recovery After Arthroscopy: Tailored Pathways to Sport and Work Reintegration

Explore evidence-based strategies and personalized approaches to optimize post-arthroscopy recovery and support a safe, efficient return to sport and work.

Don’t miss this opportunity to learn more about rehabilitation approaches.

Save the date 📅 to connect with us at our booth to discuss our musculoskeletal and dry eye therapies, as well as opportu...
29/09/2025

Save the date 📅 to connect with us at our booth to discuss our musculoskeletal and dry eye therapies, as well as opportunities in in-licensing, out-licensing, and global distribution.
👉 Learn more about our expertise and CPHI Europe 2025
https://bit.ly/3Vk4mEc

We’re proud to exhibit at ISIAT 2025, where global experts in intra-articular therapy will explore the latest in viscosu...
11/09/2025

We’re proud to exhibit at ISIAT 2025, where global experts in intra-articular therapy will explore the latest in viscosupplementation, orthobiologics, and more. From consensus updates to joint preservation in athletes and ultrasound-guided injection workshops, this edition brings valuable insights for specialists in joint and musculoskeletal health.

💬 Meet the at Booth E in Bucharest and discover how our Swiss-engineered solutions are advancing joint care and mobility.

👉 Learn more about our MSK expertise and ISIAT 2025 events https://bit.ly/47ME0lD

04/09/2025

Osteoarthritis in small joints and TMJ can be a real challenge in clinical practice. Here’s a chance to deepen your expertise in just 45 minutes with a leading voice in the field.
📅 Date: Monday, September 29th
⏰ Time: 7:15 – 8:00 PM (CEST)
Join us for a focused clinical webinar on small joint and temporomandibular joint (TMJ) management, led by Stefano Stea, a consultant oral and maxillofacial surgeon in the UK. Register here https://one.wisembly.com/trbacademy

Mark your calendars and join us at ESCRS 2025 in Copenhagen, from 12–16 September!We will be exhibiting at Booth C4.018 ...
25/08/2025

Mark your calendars and join us at ESCRS 2025 in Copenhagen, from 12–16 September!
We will be exhibiting at Booth C4.018 and are excited to present our latest solutions in ocular surface health.

This year’s congress features exciting extras like the BoSS sustainability track and the 5K Charity Run through Amager Fælled, making it a must-attend event for ophthalmologists committed to innovation and impact. We look forward to connecting with you in Copenhagen!

Adresse

Route Des Jeunes 33bis
Eaux-Vives
1227

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TRB Chemedica International erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an TRB Chemedica International senden:

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Notre histoire

We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.

Founded by Dr Guido Di Napoli in 1980, TRB Chemedica followed a gradual business evolution and expansion through the development of a worldwide network of subsidiaries and distributors.

For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology.

Our medium-sized company, supported by an exclusive network of affiliates, agents and partners, makes us efficient and responsive in the market, with the ability to develop customized solutions for patients and partners in our three focus areas that are hyluronic acid diacerein and GM1 ganglioside.